Quantitative prediction of CYP2D6-mediated drug interactions

被引：0
|
作者：
Tod, M.
Goutelle, S.
Clabel-Grabit, F.
Nicolas, G.
Charpiat, B.
机构：
[1] Hop Croix Rousse, F-69317 Lyon, France
[2] Hosp Civils Lyon, Lyon, France
[3] Univ Lyon, Lyon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
1
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] In Silico Model for Predicting CYP2D6-Mediated Drug-Drug Interactions
    Lozano, Roberto
    Frutos, Alberto
    Martinez, Alejandro
    [J]. CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (02) : 124 - 127
  • [2] Physiologically-Based Pharmacokinetic Modeling for the Prediction of CYP2D6-Mediated Gene-Drug-Drug Interactions
    Storelli, Flavia
    Desmeules, Jules
    Daali, Youssef
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (08): : 567 - 576
  • [3] Unimolecular and Bimolecular Binding System for the Prediction of CYP2D6-Mediated Metabolism
    Sato, Kimihiko
    Yamazoe, Yasushi
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (03) : 486 - 496
  • [4] Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions
    Michel Tod
    Sylvain Goutelle
    Fannie Clavel-Grabit
    Grégoire Nicolas
    Bruno Charpiat
    [J]. Clinical Pharmacokinetics, 2011, 50 : 519 - 530
  • [5] Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions
    Tod, Michel
    Goutelle, Sylvain
    Clavel-Grabit, Fannie
    Nicolas, Gregoire
    Charpiat, Bruno
    [J]. CLINICAL PHARMACOKINETICS, 2011, 50 (08) : 519 - 530
  • [6] Physiologically Based Pharmacokinetic Model Verification and Improvement for CYP2D6-mediated Drug-drug Interaction Prediction
    Ning, Miaoran
    Posada, Maria M.
    Hall, Stephen D.
    Dickinson, Gemma L.
    [J]. FASEB JOURNAL, 2017, 31
  • [7] CYP1A2-AND CYP2D6-MEDIATED INTERACTIONS WITH CENTANAFADINE IN HEALTHY ADULT SUBJECTS.
    Mehrotra, S.
    Bricmont, P.
    Gordon, J. R.
    Shoaf, S. E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S63 - S63
  • [8] Quantitative prediction of CYP1A2-mediated drug interactions
    Gabriel, L.
    Tod, M.
    Goutelle, S.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 12 - 12
  • [9] Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data
    van der Lee, Maaike
    Allard, William G.
    Vossen, Rolf H. A. M.
    Baak-Pablo, Renee F.
    Menafra, Roberta
    Deiman, Birgit A. L. M.
    Deenen, Maarten J.
    Neven, Patrick
    Johansson, Inger
    Gastaldello, Stefano
    Ingelman-Sundberg, Magnus
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    Anvar, Seyed Yahya
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (603)
  • [10] CYP2D6-mediated mexiletine-protein adduct formation
    Saito, Y
    Saeki, M
    Maekawa, K
    Hachisuka, A
    Teshima, R
    Ozawa, S
    Sawada, J
    [J]. JOURNAL OF HEALTH SCIENCE, 2004, 50 (01) : 82 - 85
12345